Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01698775
What this trial is testing

Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 213
Testing effectiveness (Phase 2)Study completedNCT00976495
What this trial is testing

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 154
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Large-scale testing (Phase 3)Study completedNCT02577003
What this trial is testing

Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT01646320
What this trial is testing

Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 320
Testing effectiveness (Phase 2)Study completedNCT01240759
What this trial is testing

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Shionogi 218
Large-scale testing (Phase 3)Study completedNCT02630706
What this trial is testing

Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 506
Post-approval studies (Phase 4)Ended earlyNCT00283049
What this trial is testing

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 390
Post-approval studies (Phase 4)Study completedNCT01438814
What this trial is testing

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 689
Large-scale testing (Phase 3)Study completedNCT02582814
What this trial is testing

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 151
Large-scale testing (Phase 3)Temporarily pausedNCT01257412
What this trial is testing

Evaluation of Efficacy and Safety of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control With Diet and Exercise Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 375
Large-scale testing (Phase 3)Study completedNCT01697592
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 585
Large-scale testing (Phase 3)Study completedNCT01128153
What this trial is testing

Saxagliptin Triple Oral Therapy

Who this might be right for
Type 2 Diabetes
AstraZeneca 257
Large-scale testing (Phase 3)Study completedNCT00855166
What this trial is testing

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 182
Post-approval studies (Phase 4)Study completedNCT02589639
What this trial is testing

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 269
Not applicableUnknownNCT04267601
What this trial is testing

Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 2,448
Large-scale testing (Phase 3)Study completedNCT01217892
What this trial is testing

Evaluation of Dapagliflozin Taken Twice-daily

Who this might be right for
Type 2 Diabetes
AstraZeneca 400
Large-scale testing (Phase 3)Study completedNCT00541775
What this trial is testing

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 273
Large-scale testing (Phase 3)Study completedNCT00087516
What this trial is testing

Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 741
Large-scale testing (Phase 3)Study completedNCT01214239
What this trial is testing

Efficacy and Safety Study of Linagliptin (5 mg Administered Orally Once Daily) Over 24 Weeks, in Drug naïve or Previously Treated Type 2 Diabetic Patients With Insufficient Glycaemic Control

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation